Jack A. Khattar - Feb 22, 2024 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role: President, CEO, Director
Signature: /s/ Timothy C. Dec, as attorney-in-fact
Stock symbol: SUPN
Transactions as of: Feb 22, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/26/2024, 05:01 PM
Previous filing: Feb 22, 2024
Next filing: Feb 29, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SUPN	Common Stock						897K	Feb 22, 2024	Direct
holding	SUPN	Common Stock						1.02M	Feb 22, 2024	By the KBT Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SUPN	Employee Stock Option (Right to Buy)	Award	$0	+322K		$0.00	322K	Feb 22, 2024	Common Stock	322K	$27.94	Direct	F1
transaction	SUPN	Performance Share Unit	Award	$0	+35K		$0.00	35K	Feb 22, 2024	Common Stock	35K	$0.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests in four equal annual installments beginning on February 22, 2025.
F2	On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023.